±Æª¾ç©ÉÈÁÄ¢éD

Dwmim»óÜ¸Cq{àÙ­çxÆáo¶ÌdÌíªÉ¨¯é«Ìi¦ÍCñ15÷ÙÇÌlÅÙÚêèµÄ¢éÆ¢¤f[^ªÁCYCOújCÙÕÉÖWµ½DP¹ÇéiOuÙÕEíÊÙÕú£jCV¶EûªC±êðNîwÊÉÝéÆC40ãC50ãÅÍSiûcËRÇóQFSIDSjÆÌÖAÉÂ

¸­XüÉ

èC20ãC30ãÅÍã¸XüÉ¢ÄÍC»ÌöÊÖWÍ¾ç©ÅéÆ_Ã¯éDÆ­É20ã«Ìi¦Ìã¸XüÍµçêé¾¯Ì\ªÈØª¶Ý·éDÜ½Cs­C»Ý20ã«Ìñ 4 lÉ 1 lªCiµÄDC¬YCq{ODPÆÌÖAÉÂ¢ÄàC½­¢éÆ¢¤»óªÌGrfXª¶Ý·éµCéi}PjD±êÉºÁÄDwÌiàÁXüÉèCú¶J­ÈÌ²¸éíÌï`iûWôC¹Cà½«CñªÒÅÈÇjÆÌÖAÉiûcgÌ­ç²¸jÉæéÆC1990NÉÍÂ¢ÄàC­ÅÍ

5.6÷ÅéDDwÌiÆÌ¬·áQCwKáQâCÁ½i¦ªC2000NÉÍ10÷ÆC2{ß¢Éã¸µÄ¢é1)DÌ_o­BÙíCÄzínâAM[¾³ÖÌáN«âDwÌiªÁµÄ¢éwiÉÍC^oRïÐÌ«ð^[QbgÆµ½¤iJ­Cé`íªÆC«ÌÐïioÈÇªë³¦CìâAa­Ç¦ÈÇÆÌÖAð_¶½_¶àU©³êé2`9)DéD»êÉt·éâè_ÆµÄC³ç¨æÑÆëEÐïÂ«Ì®õCîñÌJ¦Æ`BCfÃ»êÉ¨¯é¡ÃEw±ÌOêÆ¢Á½OÂÌdvÈÎô
Ìs\ª³ªéªGrfXª¶Ý·

DwmijnhmEiXüKAJ½­ÌlÍC^oRÍgÌÉæ­È¢Æ¢Á½
RÆµ½C[WðàÁÄ¢éDÆ­ÉDPµéD½«ÍCÙÉ«e¿ðyÚ·àÌÍð¯½¢Æ¢¤v¢ªDPjÎXime¿mêÊ_Ìgpðð¯½ªéD±Ìæ¤ÈCDwªiDPÉÎµÄiªÇÌæ¤È«e¿ðyÚ·©ÉÂ¢ÄÍC½­Ì¤ñªmKey words nèCêÊIXüÆµÄCòÜÈÇèCÈºÌ·é±Æªæ­È¢Æ¢¤l¦ÍärIZ§µÄ¨èCDPð«Á©¯Éiðf·épxÍä

DP#i#Öw±
ú{zÂíwïêåãzÂíêåãæABªæQ B@@DNXCDE}PKjIP«mi¦

ú{êöÐ¨æÑú{½Î±YÆ®ïÐ­\Ì¿àÌlæèì¬}QDwmi¦Feí²¸Ãô»märrI¢i}QjDDP·é±ÆÍå«ÈÖÌ«©È»fÅâßÄµÜÁÄàCi¾¯Í±¯ÄÁ©¯ÉÈé±Æª±êÅí©éDMuchowski¢éDwÉö·é±ÆàfÃÌêÅæ­o±·çÌréD±êÍCòÜpÆáÁÄÚÉ©¦é`Åi[ÅàC¢ë¢ëÈÖîüû@ÆCDPÌîüÆðärµÄCDPÌîüÍøÊIÅ

é±Æª¦³êÄ¢é10)Dµ©µÈªçCDPð«Á©¯ÉòÜÌpðCDF

ú{zÂíwïêåãð±¯Ä¢éDwªÊíÌDPoßð½ÇÁÄoYÉ¢½Á½ÀáðÝÄ¢éo±ªé±ÆâC^oRÉ½­Ì»w¨¿ªÜÜêÄ¨èCzÂíêåãæABªæQ B@@DNXòÜÈãÉLQÅé±ÆðmçÈ¢±ÆCjR`Ë¶Ì½ßÈPÉâßçê¸CÜ½CXgXðÁÉKvÆM¶Ä¢é±ÆCÈÇªÖWµÄ¢éD±ÌªÉÂ¢Äîñð^¦Cw±·éðªCãÃ]ÒÉßçêéD±Ìæ¤ÉDPúÉÖÅ«È©Á½DwÍCÖÌ«Á©¯ð¸¢Cið±¯éXüªéDÇÌæ¤ÈîñªDwÉÖð£·¤¦ÅøÊI©Ì²¸ªCºÉ§F{sÅsíê½D±êÉæéÆCärIæ­mçêÄ¢éYâáÌdÌÁÆ¢Á½îñÌFmxÍCiðâß½D
wÆC±¯½DwÆÌ

¢¾Å·ªÈ©Á½ªC

SIDS ÈÇÌîñÌFmxÅÍ·ªé±Æªí©Á½D±Ì²¸ÊÍCæ61ñú{öOq¶wïÅ­\³êCz[y[WãÅöJ³êÄ¢é11)D}RiÎôæijIPDwim¸­m^mûôµÄ¢é©Æ·­ÌÅÍÈ­C}SÌæ¤È¿âDwÌið¸ç·½ßÌûôÆµÄÍCÂ«®õÆãÃ»êÅÌw±E¡ÃÌ 2 ûü©çÌ
û@ªéDÄÌ}T`ÄÚ±½áô·¿ÀBjIP­ôOcm°ôI@Nãjg#Dwmi¦mÚçiAI\ðpÓ·é±ÆªøÊIÅéDÜ½CióµÌmFEÖÌw±ãàCf@Ì½ÑÉñióµðmFµCæè³mÈmFû@iAR`[ZbcBÅÍ1990NãÉCjvªÈÇjà¹p·é±Æð§µÄ¢éDi¦ð¸­³¹é½ßÌûôÆµÄCOÂÌFiore ÍCñÌióµÌmFðfÃÌî{ÆS[ðÝèµ½æègÝªÈ³ê½D±ÌS[¨¦CgThe new vital signhÆ\»µÄ¢é13)D¨æÑÊð}RÉL·DÄSÌÅàCDwÄðSÆµÄC1983Næè 4 iKÌtF[Ìi¦Í¸­µCNational Birth Certicate ÌYðdËÄ]¿³êÄ«½CSCRIPT (The Smo­1999NÌñÉæéÆC1990NÉ¨¯é33÷©

king Cessation or Reduction in Pregnancy Treat­ç 1999 N É Í 12÷ Æ È Á Ä ¢ é D ± Ì æ ¤ Èmentj\bhÆ¢¤àÌªCiÒÆµÄcéàÌÍCá¾ÒwâáwÔÅ¢©ÉøÊIÉw±·é©CVXe}eB

ðwÉ½¢Æ¢¤XüªÝçêÄ¨èC±±ðÇbNÉÂ­çêÄ¨èCDwÌÖÉÖµÄ]

¤·é©Æ¢¤V½ÈÎôªKvÆÈÁÄ¢éD

Ìû@Ì{ÌøÊðéi}T)14)DZ°Ä¢éD±ÌÅÍCzThe Agency for Healthcare Research and Qual­z¿âCrfIÆ¢Á½\[Xªgp³êéD

ity ( AHRQ j É æ é 2000 N Ì Clinical PracticegA Pregnant Patient's Guide to Quit Smokingh

Guideline ÅÍCDwÖÌÖw±ÌæêàÍC

ÍC40y[WÌûqÅióµð³mÉ]¿·é±ÆÅÍCÈÕIÈ\[XÆµÄC1 Ì[tbgèC½æèàfÉîü·é±ÆªàÁÆàdvÅéÆq×Ä¢é12) DÆ­ÉCÅÌâfÌÆ«ÉCæÌ\ÉbZ[WCéD±ÌÙ©ÉÄÅÉÖL^ðLü·éªðüê½àÌªpÓ³êÄ¢éi}UjD

è³mÉióµðmF·é½ßÉÍC½¾i
ú{zÂíwïêåãzÂíêåãæABªæQ B@@DNXCDG}SDwmióµc¬X^m¿â\}TCDH

ú{zÂíwïêåãSCRIPT ÞÃçzÂíêåãæABªæQ B@@DNX}UÄÛNÇì¬mDwüPæôÑè¿Äi¶F\#EFªDPÉyÚ·e¿ÉÖ·ém¯ªs\ªÈ±ÆKmãÃ@Öm»óÈÇÅíªÉÍCSIÉyµ½Dwü¯³ÞÍ©½çÈ¢DãÃ»êÂXÅÌÎÉÍ{ÝÔÅå«È·ª)

éD±ÌAP[g²¸ÍCÎÛðâµÄp±³êÄ¨èCWvÌÌ¿Cñ·é\èÆµÄ¢éDèC¡ÌÆ±ëSIÈKÍÅDwÌið¸ç·LøÈû@Í±ü³êÄ¢È¢D21¢IªÉ¨¯éêqÛÌ¯^®vægâ©eq21hðó¯ÄCe©¡Ìå±ÅæègÝªÈ³êÂÂèC±Ì®üÉúÒµ½Â«®õmKv«íªÌDwÌið¸­³¹éÚIÉÎµÄCàÁÆàøÊIÈ±ÆÍCãÃ]ÒÌ³ç
Æ³ÞÌJ­EñÅ¢DíªÌãÃ»êÉÍÇÌæ¤ÈâèªéÌ©D¡ñCãtðÎÛÉDwÌiÉÖ·éAë¤ÆvíêéªC±ÌÙ©ÉáNÒ¨æÑeÌ¢ãÌ³çâCÐïEÆëÂ«Ì®õàÜ½CKv«Í¢DP[g²¸ðs¤±ÆÆµCÌåÈãÃ@Ö^oRªÈPÉ¢¬NÒÌèÉnçÈ¢æ¤ÉÅpCbg²¸ðsÁ½D18{ÝÌ69l©ç·éûôilã°C©®Ì@ÌPpjÍC}ñª¾çê½D69lÌàóÍCj«55lC

ÉÈ³êÈ¯êÎÈçÈ¢µC}XR~ðÊµÄ«14lÅÌîññâC³ç»êÅÌÂ«®õàÏÉIÉèCSÌÌi¦Í30÷Å

Á½D±±©çÝ¦Ä«½âè_ÆµÄÍCDwÌisíêé×«ÅóµÌc¬ª\ªÉÈ³êÄ¢È¢±ÆCDwðé±ÆÍOÉq×½ªC¬YâÙï`ÆÌÂÈi³¹éw±@ªgÉÂ¢Ä¢È¢±ÆCiªèðl¦éÆC{ÍDPO©çÖµÄ¢È

ú{zÂíwïêåãéDDPªÖÌ«Á©¯ÉÈzÂíêåãæABªæQ B@@DNXCDI¯êÎÈçÈ¢DwlÈÌãtà»Ì±Æð«¿ñÆF¯µÄfÃÉ½é×«ÅéDÖÉ¬÷µ½DwàCoYãÉÄiµÄµÜ¤±Æªæ­èC±êðh®±ÆàYêÄÍÈçÈ¢DDPð«Á©¯ÉüÍÌÆ°àÖ·é±ÆªzÅéµCü@Éi·éêð^¦È¢½ßÉàCãÃ@Öð®SÖ»·é±Æ
ªKvÅty. Am J Epidiol 1988; 127: 274_2825) Hofhuis W, de Jongste JC, Merkus PJFM: AdverseéDhealth eects of prenatal and postnatal tobacco smoke
exposure on children. Arch Dis Child 2003; 88: 1086_10906) Sekhon HS, Jia Y, Raab R et al: Prenatal nicotine
increases pulmonary a7 nicotinic receptor expression
and alters fetal lung development in monkeys. J ClinInvest 1999; 103: 637_647
7) Holgert H, Hokfelt T, Hertzberg T et al: Functionaland developmental studies of the peripheral arterial
chemoreceptors in rat: eects of nicotine and possibleIjrelation to sudden infant death syndrome. Proc NatlAcad Sci USA 1995; 92: 7575_7579

íªÉ¨¯éDwÌi¦ÍCã¸XüÉ8) Beaty TH et al: Testing for interaction between mater­éÆ¢¦ÇàCOÉä×éÆÜ¾á¢lÅnal smoking and TGFA genotype among oral cleftéDêÌOÀÉÈÁÄµÜ¤OÉC·Åcases born in Maryland 1992_1996. Cleft PalateÉi¦ÌáºÉ¬÷µÄ¢éÉ¨¯éûôÆ¢¤Cæ¢©{ðpÅ«éÆ¢¤¡ªCíªÌDwÌi¦ðá­ÆÇßC©Â[ðÚw·±ÆÌÅ«é`XÈÌÅq¶cohort. BMJ 2002; 324: 26_27
evidence supporting periconception health care. J FamPract 2004; 53: 126_133q1) ú¶J­ÈÙpÏE¶ÆëÇF½¬12Nûcg11) Rªë°F
qhttp://www1.sumoto.gr.jp/shinryou/kituen/r12) Fiore M, Bailey W, Cohen S: Treating tobacco use andÌ­çñi½¬13N10j2) US Department of Health and Human Services (2001)

dependence. Clinical practice guideline. AHRQ. Rock­Smoking and women's health: A report of the Surgeonville (MD): US Agency for Health Care Policy andGeneral. Rockville; USDHHS

Research, June 2000

3) Naeye RL: Abruptio placentae and placenta previa:
frequency, perinatal mortality, and cigarette smoking.
Obstet Gynecol 1980; 55: 701_704
eects of maternal smoking on fetal and infant mortali­

ú{zÂíwïêåã13) Fiore M: The new vital sign: assessing and document­
ing smoking status. JAMA 1991; 266: 3183_318414) Windsor R: Smoking cessation or reduction in pregnan­

4) Kleinman JC, Pierre MB Jr, Madans JH et al: TheCE@cy and diabetes mellitus in a British longitudinal birth10) Muchowski K, Paladine H: Anounce of prevention: theéD£

Craniofac J 1997; 34: 447_454
9) Montgomery SM, Ekbom A: Smoking during pregnan­cy treatment methods: a meta­evaluation of the impactof dissemination. Am J Med Sci 2003; 326: 216_222

zÂíêåãæABªæQ B@@DNX